Latest Strategic Focus News

Genetic Signatures has completed a major restructure delivering $5 million in annual savings from FY2027 and secured a decade-long supply contract with Denmark’s Hvidovre Hospital, while posting $14.8 million revenue for FY2026 amid market pressures.

Investigator Silver has moved the Paris Silver Project decisively from study to execution, bolstered by a strong cash position and key executive hires to drive development and financing.

Connexion Mobility Ltd delivered a standout Q4 FY26 with 12% revenue growth to $3.4 million and an 83% jump in net profit before tax, fuelled by software subscription gains, GM Canada’s Enhanced Exposure Program, and the strategic acquisition of Hallam Road Automotive.

Careteq Limited (ASX: CTQ) has confirmed it will maintain its ASX listing after selling its Embedded Health Solutions subsidiary, shifting its strategic focus entirely to its HMR Referrals platform. The company reported positive operating cash flow in the March quarter and outlined plans to expand its pharmacist and GP networks while exploring AI and adjacent healthcare opportunities.

Dimerix has strengthened its kidney disease pipeline with a US patent grant for DMX-652, extending protection until 2043 and setting the stage for a Phase 2 trial targeting acute kidney injury after cardiac surgery.

Green360 Technologies has locked in its inaugural commercial supply contract with Holcim Australia for up to 4,800 tonnes of its MKX-CC low-carbon cement replacement, marking its shift from development to commercial sales amid tightening supplementary cementitious material supplies.

RAM Essential Services Property Fund (ASX: REP) has agreed to sell five retail properties to an institutional investor-backed fund, retaining a 10% stake and realising $218.6 million in value. The move reduces REP’s gearing to around 16% and rebalances its portfolio to 74% healthcare exposure.

Locate Technologies’ Q4 FY26 update highlights a 54% surge in Locate2u revenue to NZ$1.20 million, driving normalised EBITDA into positive territory. AI integration accelerated product development and customer onboarding, while capital moves included a share buyback and royalty conversion.

Carnegie Clean Energy has secured $2.5 million through a share placement, attracting new overseas investors to fund expansion of its CETO wave energy technology at BiMEP in Spain and commercial activities in Europe and the US.

Cleanaway Waste Management appoints Nigel Simonsz as new CFO following Paul Binfield’s departure, while confirming FY26 underlying EBIT at around $470 million, mid-point of prior guidance.

Ariana Resources reports steady progress at its Tavşan gold mine in Türkiye with ramp-up completed and operational enhancements ongoing, while moving to simplify its Turkish portfolio by planning a sale of its Kiziltepe interest.

PYC Therapeutics has secured Safety Review Committee approval to escalate dosing in its Phase 1b trial of PYC-003 for Polycystic Kidney Disease, alongside regulatory clearance for an Open-Label Extension allowing continuous dosing up to 24 months.